NCT02672527View on ClinicalTrials.gov

Trial Comparing Trabectedin to the Best Supportive Care in Patients With Sarcoma

PHASE3CompletedINTERVENTIONAL
Enrollment

103

Participants

Timeline

Start Date

January 22, 2015

Primary Completion Date

July 14, 2018

Study Completion Date

July 14, 2018

Conditions
Soft Tissue Sarcoma
Interventions
DRUG

Trabectedin

DRUG

Dexamethasone

Trial Locations (1)

94805

Gustave Roussy Cancer Campus Grand Paris, Villejuif

All Listed Sponsors
lead

Gustave Roussy, Cancer Campus, Grand Paris

OTHER

NCT02672527 - Trial Comparing Trabectedin to the Best Supportive Care in Patients With Sarcoma | Biotech Hunter | Biotech Hunter